Philip Morris
A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
Fields
- Author
- Reverente, B.R.
- Weetman, D.F.
- Wongphanich, M.
- Weetman, D.F.
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- ABST, ABSTRACT
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Characteristic
- EXTR, EXTRA
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Named Organization
- Intl Conference Indoor Air Quality Asia
- Author (Organization)
- Iai, Indoor Air Intl
- Mahidol Univ Bangkok
- Philippine Refining
- Univ of Sunderland
- Mahidol Univ Bangkok
- Site
- R529
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- qic02a00
Document Images
UNDOOR AIR QUALITY Il~T ASTA
Proceedings of the International Conference He1d at the Central Plaza
Hotel', Bangkok, Thailand on 28'-29th November, 1991.
Edited by
B. R. Reverente Jun
Philippine Refining Co Inc
1351 United~ Nations Avenue
Mani1ia
PO BOx 1176
PliilipPpines
D. F. Weetman
School of Health, Sciences
University of Sunderland
Sunderlan&
England~
and'
AS. Wongphanich
Occupational: Health Department
Faculty of Public Health
Mahidol University
420/1 Rajvidhi Road
Banokok 10400
Thailand
Published by
Indoor Air International
The InternationalU Associataon for Indoor 4irQualitv,
Postfach 2
CH-4467 Rothenfluh
Switzerland
ISB.N 3-906470=001S
April 1993
1

,
Indoor Air Qualin,, Ventilation and Enerp7 Saving
Qigao Chen
,
Refrigeration Using Waste Heat To Improve Working
Condiuons. Jiajie Liu, Xianying Liu and Chunw-u Sun~
Reliability of Quesuonnaire Data. Jun b:aSa,wai
A Survey of' the Quality of Indoor Aii in Manila Office
Buildings. Benito R. RevereriteJr.
Sources of Polltition
The Effect of Outdoor Air Pollution on The Mortality of
Indoor Residents. l:in-hua Chen and Qih-uan Deng
Industrial Pollution in Vietr,am: An Important Ea-ternal'
Source of Ind'oor Air Polllrtion. Le Van Trung,
The Environmental Impacr of Carcinogens from Motor-Car
Exhausts. Manfred Buck
Identification of the Sources of Airborne Particulate Matter
in Urban, Suburban and Industrial Areas of Korea.
Sung-Ok Baek and Myuns Ho Hahn~
Non-occupational Exposure to Lead in an~
Occupational Setung; Eiji Yano
Sources And Indicators Of Indoor Air Pollution In
The Occupauonal! Setting. D. Soedirman
Airborne Asbestos Concentrations in, Rooms 'with
Sprayed-On :A-sbestos Materials. Iziiyoshi Sakai,.
Naomi Hisanaga:, I:azunori Mitani Hironobu Tsuchiva,
Itian Huang, Eiji Shibata, Yuichiro Ono, Akinori Kojima
and Yasuhiro Takeuchi'
The Contamination of Indoor Air with Asbestos and
Man-made Mineral Fibres. John A. Hoskins and Robert C. Bro'wn.
V1
83
97
107
117
121
127
133
141
155
161
171 ~
~
185 w
~
F"a
0
Ph
~

Concentration And Exposure Dose Of Radon And Its
Progeny In Public Bath Houses at Two Hot Springs.
Qing-Xiang Zeng, Yan Li, Zhao-Hui Huang, Hui Su,
Hong-LiniWang, and~hiu-Ian Hui
95
Level and Dose of Radon and Its Progeny in linderground
Buildings in Wuhan City. Qing-Xiang Zeng, Yan Li,
Zhao-Hui Huang and Hong-Lin Wang.
199
RadoniConcentration in Drinkino Water and the Dose
Received by the Exposed' Population: Yibin Chen
205
Control of Welding Fumes in the Metal Fabrication Industry:
R.C. Panjwani
?13.
Control of Dusts for Small Cement Factories with Shaft Kilns.
Guangquan Liu, Jiang Liu, Chen Zhou andi Gushua Hu
2?9'
Asbestos Concentration In Indoor Air And Management,
Of Asbestos-Removal Works In Japan. Susumu Tod'a
and Mikiharu Aoyagi
237
Standardization, of the Measurement of Asbestos Fibres in
Indoor, Air. Norbert Hoefert
243
Continuous Measurement' of Indoor, Air Quality in Office
Buildings in Japan. Akiyoshi Ito
251
PIXE Application to Indoor Air Quality Measurement.
Toshitami Ro, Takeshi IShiguro;,Mitsuru Fujimura
and Yoshikazu Hashimoto
261
Health Effects
A critique of the methods used to assess the toxic effects
on maniof combustion products, Di F. aJeetman
275

Health Problerns in a Thermoelectric Plant in Vietnam,
Nguyen Do Nguyen~ Nguyen The Dung and Pham Nboc Len ?S7
Concentrauons of Pyrethroids in the Air of Dividins and Packing
Workshops. P Yao, J Sun; Y W.u, S Wang, L Liu and F He 293
Prevalence of Welders' Pneumoconiosis in Workers
Exposed to Welding Fumes. Changqi Zou,.
Kangji Xng Yanhua Yuan, Qingchens Du
Yuxi~ Hbu and! Zonsshu Mao 299 Key T
infect
Neurotoaic Effects Of Carbon Disulfide On Ravon Workers:
Fengsheng He, Zhemin Zhang; Shi Yang, and' Shoulin Zhang 305
Further Anallhses of the Role of' Confounding Variables
in Epidemiolobic Studies of Environmental Tobacco Smoke
and the Respirator}'System in School'-age Chiidren.
Raphael J, W'itorsch, JosephiM. Wu, Ronald Di Hood
and Philip Witorsch 313
n
envirc
partict.
Factor
Th(
t}ie pu
kind c
inapp-n

E
0
in order to seek a.
j within buiidings
,f air conditiotdng
ronment and willl
:hanism Of indoor
A CRTTIQUE OF THE METHODS USED TO ASSESS
'I'HE TOMC EFFECTS ON MAN OF COMBUSTION
PRODUCTS.
D, F. R'TEETMAN'N
spaces". n ' n. R _,
DOE-ER.6()493-7-vol ,~
1 Analysis. John W-del
events in Japan duriq
sources of indoor a:id -336.
as detennined by PDcE
Nucll lns4r, h'larhPho
School of Health Sciences, University of SunderJand , Sunderland,
Tyne and Wear, England
Key Words: combustion~producrs, epidemiology, risk assessment, environmental
tobacco smoke, cardiovascular diseases.
ABSTRACT
Combustion of organic material results inahe release ofpaniclds, gases,,and~pyrolyuc
products. all of which can accumulate in the indoor environment, and could damage
health. The methods of assessing risR to mamare reviewed, and it is conduded that
epidemiology provides the bestsingle approach. The problems in unerpretatiorrof
epiderniological studies are reviewed; with, particular, eemphasis on the specific
problem of environmental tobacco smoke (ETS) and cardiovascular disease. tt is
cond'uded that too many important potentially confounding factors have been
overlooked to decide if there is an, association between exposure to ETS and
cardiovascular diseases.
NATURE AND SOURCE OF CO."vfBUSTION' PRODUCTS
Iti is difficult to imagine life v,ri,hout~ combustion. In addition to domestic
heating, combustion of some form of fuel occurs in cooking, many forms of
transportation, most industrial processes and most of the generation of electrical
power. The common factor is that some form of fuel is burnt, and the fuel is
derived from organic matter, aith the inevitable release of pollutants. Not all
combustion, contributes pollutants to the indoor environment, but in those
situations where this effect appears to be minimalit should be remembered that
the indoor air is derived from, that outdoors, so the dirtier the air outside a
building; the more polluted it will be inside..
When organic matter is burnt, three classes of pollutant, are formed. Firsr.there
are gases. As the pred'orninant chemical process is oxidation, which usually
occurs without sufficient oxygen to allow complete oaidation, there is the release
of 2: complex mixture of'~ oxides. Thus amongst the gases generated bvy
combustion, there are oaides of carbon, nitrogen and sulphur.
275
3SM

Assessmenr of the Toxic Effects of ComBusrion Products
Organic molecules can undergo complex re-arrangements without, the
consumption ofoaygen in a!process called pyrolysis; which is largel', deterrriir,ed
by the temperature of' combustion. Finally, there is the generatjon of pardcles
which are the small globules of organic matter that give rise to the visibility. of
smoke. Particles vary in size, and undergo complex changes in shape andli
surface area when they cool down to the ambient temperature. Large panicle5
do not stav suspended in the air for long. Particles up to 10}en are readily i.nhaled,
and may not be rapidly cleared by from the lung;, large particles (1oj,,
aerodynamic diameter) are deposited in the upper respiratory tract whereas
small ones (O1yn) are exhaled Ill. The important aerodynamic diameter with
respeet to potenval pulinonarytoxiciry is probably about O.S;an [1]. Much the
same tnucture of gases, pyrolyuc products and particles are generated from the
combustion of any organic matter. For example, there is more similarity than
difference in the products released from burning woo& and tobacco. With
combustion of organic matter that has undergone some degree of inetamorpho-
sis; as with coal, oil and natural gas, there is variation in the proportions o;
components generated from eachs,but again there is a mixture of gases, pvrol±,tic
products and particles.
METHODS OF RISK DETERNII.hA.TIOh
investigations. Any reliable findings about risks to the health from combustion
products can be used i.n attempts to regulate levels of'the offending substances,
and~ thus protect man.,
justifi-the funds they consumeso there need to be an acceptable purpose oflthe '
The purpose of determining the risk to rnanftom combustion products arises
from~ the ubiquitous distributioni of these substances. Scientific knowledge is
sought because of man~s insatiable curiosity;, but increasingly scientists have to
Iaboratory Studies
Laboratorv animalscan be exposed to smoke and then assessed for anv effect.
However, this type of eaperimentation is fraught with difficulty. There is always
some carbon monoxide generated by combustion, which prev.ents high~doses
of smoke being administered. The anatomy of'the respiratory system of, say.,,rats, is quite
different from that of man, so it is difficult to~predict the outcome in this
latter species from effects seen in the former. Any experience of pharmaceutical
research teaches that there is no completely reliable way of translating effects
seen in laboratory animals to man. To determine what happens in man, ii is
necessaryto investigate in man.
Direct eaperimentation in man can be achieved'in exposure chambers. The
problems here are that exposure must be shon-teran, and there is still an upper
?76
ltmit to the dosc
course,,it is pos
to volunteers ir
but then it is b:,
components.
administering
in vitro svster
inadequate for
Epidemiolog,
It is possil
combustion p
population of
outcome in th
study designs
with a conditi
to the suspea,
The second'a;
determine wi
method does
causes of d'ea
summarises t:
Table 1 Prc
The bes:
gation is to
regulators 2
exposure to
ate exampl(
disease. so
the investii
products fr

Assessment of the Toxic Effects of'Combustton Products
without the ~
determine&
of particles,
e visibility of'
nishape and
irge particles
3dilv inhaled,
-icles (10Fan
-act, whereas
iiameter with
_1 . Much the
ated from the
irnilarity dian
bacco With
: netamorpho-
roportions of
ises, pyrolytic
~1 )ts arises
knv.wledge is
2ntists have to
ourpose of the
rn combustion
ag substances,
i for any effect-
here is always
nts high doses
:em of, say, rats
)utcome in this
:)harmaceutical
aslating effects
zs in man; it i5
-hambers. 'rne
:s sull an uppef
limit to the dose that can be tested due to the presence of carbon monoxide. Of
course, it is possible to separate the various chemicals in smoke, and apply them
to volunteers in exposure chambers, either individually, or in defined mixtures,
but then it is barely possible to measure any interactions between the differenrt
components. Anv reduction in the scale of the test system, for example by
administering smoke to tissue cultures, still involves an extrapolation from the
in vitro svstem to intact man. The experimental methods available are
inadequate for this purpose.
Epidemiology
It is possible to measure the effects of long-term exposure of man~ to
combusnon products by epidemiological techniques. With this approach; a
population of exposed individhals is identified and the rate of any medical
outcome in this group is compared with that in a suitable controligroup. Two
study designs are possible. First, one can either start by identifying individualss
with a condition (i.e: cases) and attempt to show a greater exposure in; the past
to the suspected cause thanloccurs in a demographically matched control group..
The second approach is to assemble a population (i.e. cohort) of individuals and
determine what happens to them medically over several' years. The cohort
method does not provide rapid answers, especially with the most frequent
causes of deathwhich frequently have a slowly developed pathology. Table 1
summarises the problems associated with such studies.
Table 1 Problems in Epidemiology
4.
5:.
Selection of exposure and control groups
Multifactorial nature of disease
Difficulty imcontroV?ing,confounding variables
Only associations detected
Intervention studies are difficult.
The best way to understand the difficulties of such epidemiological investi-
gation is to examine the quality of the evidence in a specific case. As the
regulators are currently considering the health effects that may result from
exposure to environmental tobacco smoke (ETS), this will serve as an appropri-
ate example. The latesn claims are that ETS is causally relatedto ischaemic heartt
disease, so the quality of this evidence will be considered in detail. However,
the investigator is confronted by comparable difficulties with, combustion
products from any fuel source.
277
E
M
0
0
®

Assessment of the ToxicEffects ofCombusrion Products
Study Design
The study design is shown in figure 1. The exposed group are obtainedby
selecting non-smokers who are married to smokers,, whereas non-smokers
married to non-smokers provide the unexposed group: The rarlonale of tlis
design is that the non-smokers (usually wives) would be exposed to ETS in the
home from the smoking of their spouses. With these two populations, it is
possible to compare the rates for ischaemic heart disease, either in ~ case-control 1
or cohort studies, The problems of interpretation arise from the imprecise
distinction between the two exposure groups, and because there is no allowance
made for exposure to ETS outside the home. A second difficultyy is the
determination of' the smoking, status of the spouse, whichi is usually achieved
from the response of individuals to questionnaires. Any wTongl~ classified
partners tends to reduce the precision, of the study.
Exposed rate - events/population
J'
[ adjusted I
t
RR
EXPOSED RATE
UNEXPOSED RATE
I
[ adjusted J
1
Unexposed'rate - eventsLpopulation
1
NON-SMOKER
married to a NON-SMOKER
.
A qu
~-holha
that the
[2). As
eaampl I
[3]), the
patient
If t}i
scienris~
second
to card
cardiov
risk fac:
scicntis
sugges
not to c
or behh
cardio%
studies
to be r,Mucc
by Gla:
respon
studies
suppos
Glantz
connec
study, [I
Tat
cardio,
contair
follow:
arteriostrokel
inform

0
Dbtained by:)n-smokers
nale of this
.) ETS in the
.ations it is
:ase-controt
: imprecise
:) allowance
=ulry is the
'y achieved
v classified
M
Assessment of tbe ToxicEJJects ofCombustion Products
A quite differenuset of'problpms relate to the definition of an effect. i.e. those
who have the disease. If one relies on deatli certificate information, then the fact
that the individual has died is reliable, but the cause of death is prone to error
12). As few autopsies are now performed in most countries of the world (for
er.ample, currently, less than 1'3°/p of bodies nthe USA are subjected to autopsy
[3l), the cause of death lias to be deduced' from ~ the signs and ~ symptoms of the
patient alone:
If the possible causes of' ischaemic heart disease are considered, medicall
scientists do not have an unequivocal answer. This has resulted in a sort of'
second level approach, where risk factors apparently predisposing individuals
to cardiovascular disease are identified. In other words, the aetiology of'
cardiovascular disease is considered to be multifactorial. To dateover 200 such
risk factors have been proposed by various research groups [4) (not allimedical
scientists agree with, this approach: McCormick and Skrabanek [5) have
suggested that we should refer to risk markers, as opposed to risk factors, so as
not to confuse association with causatdon): However, if there are constitutional
or behavioral characteristics of individllals that could predispose them to
cardiovascular disease, each one should be controlled! for in epidemiological
studies, otherwise they may acuas confounders, allowinganiincorrecrconclusion
to be reached.
Much of the interest in ETS and cardiovascular disease arises from a: review
by Glanz and Parmley 161, in which, the authors presented! a case that' ETS was
responsible for a proportion of the cases of the disease. Nine epidemiotogical
studies were identified in the literature (5 with a statisticallv significant effect,
supposedly from spousal exposure (7-11)), and'4 without (12-151, which allowed
Glantz and Parmley to conclude "These epidemiological studies demonstrate a
connection between ETS exposure and' death from heart disease." One other
study [16] has been added to the ones covered by Glanz and Parmley:
Table 2 contains a summary of ohe epidemiological i studies linking ETS with
cardiovascular disease. The medical endpoint varies from study to study, and
contains both "death from" and "possession of" the specified condition;, the
following conditions were taken as the endpoint: ischaemic heart disease,
arteriosclerotic heart disease, coronary heart disease, myocardial infarction,
stroke, and all cardiovascular diseases. The reliance on~ death certificate
information as the medical endpoint is also indicated in table 2.
279
M
~
®
®
FS
©
0

Assessment of tbe Tozic EJfects of Combustion Products
Table 2 The Epidemiological studies of ETS and cardiovascular diseases.
STUDY REFERENCE DISEASE END POIN'T TOTAL EVELTS 7ESTS
sig/tota]
BUTLER [121 CHD D.C ~ 0/1
HIRAYAb1A 1101 IHD D:C. 494 1/3,
GAR1A.h'D 113]1 I.HD D:C 19 0/1,0
LEE (a51' IHD * STROKE DIAGNOSIS 121 0,130
SVENDSEN 1111 CHD PA','EL 13 ?j17
HE 181! CHD DIAGNOSIS 34 24Y47.
HELSING 171 AHD D.C. 2014 10/22
HOLE I 191 ' IHD D:C + PA'.'EL 84 1/5
HUMBLE (14] All CVD D.C. 76 0/24
DOBSON [aG hiI D.C - PAN'EL 382 2!1~
Under EYELTS ;,the numbers refer, to those in the CONTROL * E7TOSED groups for the cohor,
studies. and'thenumber of'cases in the case-control studies, and give an indicauon of'the ability
of the tests to detect aneffect. The values are for males and itmalts combinedi,and both home
and work place exposure to ETS.
IHD - ischaermc heart diseasc
CHD = coronary, heart disease
AHD - anenosclerouc heart disease
Ml - myocardial' infarction
CVD - cardiovascutar disease
D.C. - death ceruficate
PANEL - evidence reviewed by a panel of' experu
DIAGNOSIS - disease deternuned by standard diagnostic techniques
The large number of comparisons made in the papers is indicated in Table
2. When multiple comparisons are made on one set of data, the comparisons
are not,truly independent(some values will be used andthen re-used indifferent
tests); so anv study containing a stausucally significant outcome willl be
considered furuher. The positive studies are re-considered in Table 3.
It has already been stated' that cardiovascular diseases are thought to, be
multifactorial in their aeuology, so anv putauve causes other than exposure to
ETS that are not controlled for will be capable of confounding.the epidemiologi-
cal studies. For this reason, some of the best established risk factors for cardiovas
cular diseases have been identified from the literature (Table 4), and the ex[ent
of the control over these potential confounders has been detemlined (Table 3).
-i
Table 3 Missing
epidem
S7L'D1..
HIRA1'A'`!A 110)
SvEI\'DSEI\ I1'1]1
HE [8]
HELStN'G [ 71
HOLE 19)
DOBSON' 1]61
in no study was the :
Fami]y history of ca:
[81- The Svenden
behaviou:.
Table 4 The be:
RISK FACTOR
Family history, of' d.
H,vpenension
Cigarette smoking
Dietrv fat loa&
Diabetes
Lack of exercise
h9enopausal' status.
Alcohol l consumpuc
Obesu}
From table 3 i
same standard.
Svendsen et a] (`.
exposure to ET`
concentration).
dietan~ fat intakc
population selecti
the U.S. populati
The cardiovascui
were high blood
and those most a
anvy effect of ETS
